Biogen reanalyzes studies, presses ahead on Alzheimer's drug

The drug company Biogen Inc. says it will seek federal approval for a medicine to treat early Alzheimer's disease, a landmark step toward finding a treatment that can alter the course of the most common form of dementia

Source: ABC News: Health - October 22, 2019 Category: Consumer Health News Tags: Health Source Type: news